Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 110

1.

Allopurinol and risk of benign prostatic hyperplasia in a Finnish population-based cohort.

Kukko V, Kaipia A, Talala K, Taari K, Tammela TLJ, Auvinen A, Murtola TJ.

Prostate Cancer Prostatic Dis. 2017 Dec 22. doi: 10.1038/s41391-017-0031-8. [Epub ahead of print]

PMID:
29273728
2.

Prognostic factors of prostate cancer mortality in a Finnish randomized screening trial.

Neupane S, Steyerberg E, Raitanen J, Talala K, Pylväläinen J, Taari K, Tammela TL, Auvinen A.

Int J Urol. 2017 Dec 10. doi: 10.1111/iju.13508. [Epub ahead of print]

PMID:
29224236
3.

Health-related quality of life in different states of breast cancer - comparing different instruments.

Rautalin M, Färkkilä N, Sintonen H, Saarto T, Taari K, Jahkola T, Roine RP.

Acta Oncol. 2017 Nov 15:1-7. doi: 10.1080/0284186X.2017.1400683. [Epub ahead of print]

PMID:
29140139
4.

A Four-kallikrein Panel and β-Microseminoprotein in Predicting High-grade Prostate Cancer on Biopsy: An Independent Replication from the Finnish Section of the European Randomized Study of Screening for Prostate Cancer.

Assel M, Sjöblom L, Murtola TJ, Talala K, Kujala P, Stenman UH, Taari K, Auvinen A, Vickers A, Visakorpi T, Tammela TL, Lilja H.

Eur Urol Focus. 2017 Nov 11. pii: S2405-4569(17)30258-4. doi: 10.1016/j.euf.2017.11.002. [Epub ahead of print]

PMID:
29137895
5.

Renal Tumor Invasion Depth and Diameter are the Two Most Accurate Anatomical Features Regarding the Choice of Radical Versus Partial Nephrectomy.

Tornberg SV, Kilpeläinen TP, Järvinen P, Visapää H, Järvinen R, Taari K, Nisén H.

Scand J Surg. 2017 Sep 1:1457496917731186. doi: 10.1177/1457496917731186. [Epub ahead of print]

PMID:
28946808
6.

The indirect costs of palliative care in end-stage cancer: A real-life longitudinal register- and questionnaire-based study.

Haltia O, Färkkilä N, Roine RP, Sintonen H, Taari K, Hänninen J, Lehto JT, Saarto T.

Palliat Med. 2017 Sep 1:269216317729789. doi: 10.1177/0269216317729789. [Epub ahead of print]

PMID:
28895471
7.

Prostate cancer-specific survival among warfarin users in the Finnish Randomized Study of Screening for Prostate Cancer.

Kinnunen PTT, Murtola TJ, Talala K, Taari K, Tammela TLJ, Auvinen A.

BMC Cancer. 2017 Aug 29;17(1):585. doi: 10.1186/s12885-017-3579-8.

8.

A randomized trial of early detection of clinically significant prostate cancer (ProScreen): study design and rationale.

Auvinen A, Rannikko A, Taari K, Kujala P, Mirtti T, Kenttämies A, Rinta-Kiikka I, Lehtimäki T, Oksala N, Pettersson K, Tammela TL.

Eur J Epidemiol. 2017 Jun;32(6):521-527. doi: 10.1007/s10654-017-0292-5. Epub 2017 Jul 31.

PMID:
28762124
9.

Outcomes of Prostate-specific Antigen-based Prostate Cancer Screening Among Men Using Nonsteroidal Anti-inflammatory Drugs.

Murtola TJ, Vettenranta AM, Talala K, Taari K, Stenman UH, Tammela TLJ, Auvinen A.

Eur Urol Focus. 2017 Mar 24. pii: S2405-4569(17)30073-1. doi: 10.1016/j.euf.2017.03.005. [Epub ahead of print]

PMID:
28753870
10.

Statin Use and Prostate Cancer Survival in the Finnish Randomized Study of Screening for Prostate Cancer.

Murtola TJ, Peltomaa AI, Talala K, Määttänen L, Taari K, Tammela TLJ, Auvinen A.

Eur Urol Focus. 2017 Apr;3(2-3):212-220. doi: 10.1016/j.euf.2016.05.004. Epub 2016 Jun 2.

PMID:
28753762
11.

An Intraprostatic Modified Release Formulation of Antiandrogen 2-Hydroxyflutamide for Localized Prostate Cancer.

Tammela TL, Häggman M, Ladjevardi S, Taari K, Isotalo T, Lennernäs H, Weis J, von Below C, Wassberg C, Lennernäs B, Tolf A, Axén N, Gölander CG, Ahlström H.

J Urol. 2017 Dec;198(6):1333-1339. doi: 10.1016/j.juro.2017.07.072. Epub 2017 Jul 20.

PMID:
28736321
12.

The effect of non-steroidal anti-inflammatory drugs on risk of benign prostatic hyperplasia.

Nygård LH, Talala K, Taari K, Tammela TLJ, Auvinen A, Murtola TJ.

Prostate. 2017 Jun;77(9):1029-1035. doi: 10.1002/pros.23359.

PMID:
28480542
13.

Patients' perceptions of the negative effects following different prostate cancer treatments and the impact on psychological well-being: a nationwide survey.

Lehto US, Tenhola H, Taari K, Aromaa A.

Br J Cancer. 2017 Mar 28;116(7):864-873. doi: 10.1038/bjc.2017.30. Epub 2017 Feb 21.

PMID:
28222069
14.

Outcomes of Prostate Cancer Screening by 5α-Reductase Inhibitor Use.

Murtola TJ, Virkku A, Talala K, Stenman UH, Taari K, Tammela TLJ, Auvinen A.

J Urol. 2017 Feb 16. pii: S0022-5347(17)30290-2. doi: 10.1016/j.juro.2017.02.069. [Epub ahead of print]

PMID:
28216328
15.

Estimate of Opportunistic Prostate Specific Antigen Testing in the Finnish Randomized Study of Screening for Prostate Cancer.

Kilpeläinen TP, Pogodin-Hannolainen D, Kemppainen K, Talala K, Raitanen J, Taari K, Kujala P, Tammela TLJ, Auvinen A.

J Urol. 2017 Jul;198(1):50-57. doi: 10.1016/j.juro.2017.01.048. Epub 2017 Jan 16.

PMID:
28104375
16.

Antidiabetic drug use and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer.

Haring A, Murtola TJ, Talala K, Taari K, Tammela TL, Auvinen A.

Scand J Urol. 2017 Feb;51(1):5-12. doi: 10.1080/21681805.2016.1271353. Epub 2017 Jan 13.

PMID:
28084175
17.

Health-related quality of life among prostate cancer patients: real-life situation at the beginning of treatment.

Bergius S, Torvinen S, Muhonen T, Roine RP, Sintonen H, Taari K.

Scand J Urol. 2017 Feb;51(1):13-19. doi: 10.1080/21681805.2016.1247293. Epub 2016 Nov 4.

PMID:
27809631
18.

Warfarin use and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer.

Kinnunen PT, Murtola TJ, Talala K, Taari K, Tammela TL, Auvinen A.

Scand J Urol. 2016 Dec;50(6):413-419. Epub 2016 Sep 14.

PMID:
27628763
19.

Adjuvant Weekly Girentuximab Following Nephrectomy for High-Risk Renal Cell Carcinoma: The ARISER Randomized Clinical Trial.

Chamie K, Donin NM, Klöpfer P, Bevan P, Fall B, Wilhelm O, Störkel S, Said J, Gambla M, Hawkins RE, Jankilevich G, Kapoor A, Kopyltsov E, Staehler M, Taari K, Wainstein AJA, Pantuck AJ, Belldegrun AS.

JAMA Oncol. 2017 Jul 1;3(7):913-920. doi: 10.1001/jamaoncol.2016.4419.

PMID:
27787547
20.

Prostate Cancer and Socioeconomic Status in the Finnish Randomized Study of Screening for Prostate Cancer.

Kilpeläinen TP, Talala K, Raitanen J, Taari K, Kujala P, Tammela TL, Auvinen A.

Am J Epidemiol. 2016 Oct 24. [Epub ahead of print]

PMID:
27777219

Supplemental Content

Loading ...
Support Center